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Abstract
Background: Advanced age is associated with cognitive and physical decline and is a major risk factor for a
multitude of disorders. There is also a gap in life expectancy between males and females. DNA methylation
differences have been shown to be associated with both age and sex. Here, we investigate age-by-sex differences
in blood-based DNA methylation in an unrelated cohort of 2586 individuals between the ages of 18 and 87 years,
with replication in a further 4450 individuals between the ages of 18 and 93 years.
Methods: Linear regression models were applied, with stringent genome-wide significance thresholds (p < 3.6 ×
10−8) used in both the discovery and replication data. A second, highly conservative mixed linear model method
that better controls the false-positive rate was also applied, using the same genome-wide significance thresholds.
Results: Using the linear regression method, 52 autosomal and 597 X-linked CpG sites, mapping to 251 unique
genes, replicated with concordant effect size directions in the age-by-sex interaction analysis. The site with the
greatest difference mapped to GAGE10, an X-linked gene. Here, DNA methylation levels remained stable across the
male adult age range (DNA methylation by age r = 0.02) but decreased across female adult age range (DNA
methylation by age r = − 0.61). One site (cg23722529) with a significant age-by-sex interaction also had a
quantitative trait locus (rs17321482) that is a genome-wide significant variant for prostate cancer. The mixed linear
model method identified 11 CpG sites associated with the age-by-sex interaction.
Conclusion: The majority of differences in age-associated DNA methylation trajectories between sexes are present
on the X chromosome. Several of these differences occur within genes that have been implicated in sexually
dimorphic traits.
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Background
Advanced age is associated with cognitive and physical
decline and is a major risk factor for a multitude of
disorders including cancer, cardiovascular disease, and
neurodegenerative diseases. Furthermore, males and
females, on average, exhibit disparate risk profiles for
various disease states as well as different life expectancies
[1, 2]. Indeed, the average life expectancy at birth in
Scotland is 77.0 years for males and 81.1 years for females
as reported by the Life Tables for Scotland 2015–2017 [3].
Thus, markers of ageing are merited, including those
which can exploit sexual dimorphism for sex-specific
prediction of ageing and disease risk. Biological hallmarks
of ageing have been observed at the cellular and molecular
level and include shortening of telomeres, genomic
instability, and both global and local changes in DNA
methylation (DNAm) levels [4–6]. DNAm is a common
epigenetic mark, typically occurring in the context of a
cytosine-guanine dinucleotide motif (CpG). It can be
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modulated by both environmental exposures and genetic
variation and is sexually dimorphic [7].
Elastic net regression and best linear unbiased predictor
models have been used to robustly predict chronological
age by leveraging inter-individual variation in methylation
profiles [8–10]. These methodologies capture global-level
DNAm changes with respect to ageing but fail to inform
the contribution of individual loci to the ageing process.
These biological age predictors, also referred to as ‘epigen-
etic clocks’, correlate strongly with chronological age.
Additionally, for a given chronological age, an advanced
epigenetic age is associated with increased mortality risk
and many age-related morbidities [11]. Importantly, males
exhibit increased DNAm-based age acceleration relative
to females (i.e. a ‘faster ticking’ epigenetic clock) support-
ing the role of epigenetic perturbations in sex-specific
ageing trajectories [8, 9].
In 2013, Horvath proposed a pan-tissue epigenetic
clock derived from the linear combination of 353 CpGs
whereas Hannum et al. created a DNAm-based clock
based on 71 CpGs in blood tissue [8, 9]. Following on
from these seminal studies, Zhang et al. developed a
highly precise DNAm-based predictor of chronological
age (ZhangAge) limiting the value of such estimators as
biomarkers of ageing [10]. Subsequently, a new gener-
ation of DNAm-based measures of ageing was proposed.
Recently, Levine et al. proposed a powerful predictor of
lifespan and health by developing a methylation-based
predictor of an individual’s ‘phenotypic age’ (DNAm
PhenoAge) [12]. Phenotypic age is informed by chrono-
logical age and physical and biochemical measures, such
as albumin and mean cell volume. Finally, a novel clock,
termed DNAm GrimAge, was trained using mortality as
a reference and supplants predecessor clocks in predict-
ing the risk of mortality and a number of age-related
morbidities [13].
While global information relating to DNAm perturba-
tions has been harnessed to measure biological ageing,
little is known regarding the role of specific epigenetic
loci in the ageing process. Presently, age-related hyper-
methylation at the ELOVL2 locus on chromosome 6
remains the strongest known site-specific DNAm alter-
ation throughout the lifespan [14]. Methylation status at
FHL2, KFL14, C1orf132, and TRIM59 has also been
shown to exhibit linear associations with chronological
age [15]. These data may highlight biologically important
epigenetic substrates of the human ageing process. How-
ever, the loci which are differentially methylated between
males and females, in the context of ageing, merit eluci-
dation. Therefore, in the current study, we sought to
identify sex differences in age-associated genome-wide
DNAm changes, in the whole blood from a discovery
sample of 2586 unrelated individuals. These were repli-
cated in a further 4450 unrelated individuals. Both
discovery and replication sets are derived from the same
parent cohort: Generation Scotland [16]. The replication
cohort was unrelated to the discovery cohort. Further
understanding of the sex-specific effects on biological
ageing, through the identification of differentially meth-
ylated loci, may assist in identifying novel risk factors for
age- and sex-associated pathologies.
Methods
Generation Scotland: Scottish Family Health Study
Data came from the family-based Generation Scotland:
Scottish Family Health Study (GS). GS participants were
recruited from GP practices in 5 regions across Scotland
between the years 2006 and 2011 [16]. The probands
were aged between 35 and 65 years and were asked to
invite first-degree relatives to join the study, which had a
final size of 24,090. A variety of cognitive, physical, and
health data were collected at the study baseline along
with the blood or saliva samples for DNA genotyping.
Blood-based DNAm data were obtained on a subset of
5200 participants using the Illumina EPIC array [17].
Quality control details have been reported previously
[17]. Briefly, probes were removed based on (i) outliers
from visual inspection of the log median intensity of the
methylated versus unmethylated signal per array, (ii) a
bead count < 3 in more than 5% of samples, and (iii) ≥
5% of samples having a detection p value > 0.05. Samples
were removed (i) if there was a mismatch between their
predicted sex and recorded sex and/or (ii) if ≥ 1% of
CpGs had a detection p value > 0.05. For the present
analyses, we considered unrelated individuals from the
DNAm subset of GS. A genetic relationship matrix was
built using GCTA-GRM, and a relatedness coefficient of
< 0.025 was specified to exclude related individuals [18].
In cases where a couple was present, 1 individual was re-
moved to minimise shared environment effects. This left
an analysis sample of 2586 unrelated individuals ranging
in age from 18 to 87 years and 807,857 probes.
The second set of blood-based DNA methylation from
Generation Scotland was released in early 2019 and was
treated as a replication sample. This comprised 4450 in-
dividuals who were unrelated (genetic relatedness < 0.05)
to each other and to the 5200 participants from the first
Generation Scotland methylation data set. Quality con-
trol steps have been reported previously [19] and were
near identical to those reported above.
Statistical analysis
All analyses were performed in R version 3.5.3 [20].
Epigenome-wide association studies
Epigenome-wide association studies (EWASs) of chrono-
logical age, sex, and the interaction between age and sex
were performed using two approaches.
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First, we considered linear regression models adjusted
for smoking status (smoking pack-years and status—
current, gave up in the last year, gave up more than a
year ago, never, or unknown), estimated white blood cell
proportions (CD8+ T cells, CD4+ T cells, natural killer
cells, B cells, and granulocytes), methylation batch, and
20 methylation-based principal components to correct
for unmeasured confounders. Age was centred by its
mean, and sex was included as a factor. The models
were run using the limma package in R (empirical Bayes
moderated t-statistics) [21].
To remove the widespread effect of sex on X-linked
methylation, we also ran sex-stratified age EWASs on
the X chromosome. We compared this output with the
results from the age-by-sex interaction model by plotting
the –log10 p values from the interaction model against
the –log10 p value from a heterogeneity test of the
effects between the sex-stratified model: χ2hetero = (beta-
male − betafemale)
2/(SEmale
2 + SEfemale
2).
Second, we considered the MOMENT method from
the OmicS-data-based Complex trait Analysis software
(OSCA) [22]. MOMENT is a mixed linear model-based
method that can account for unobserved confounders
and the correlation between distal probes which may be
introduced by such confounders. Initially, a linear re-
gression step is performed to obtain an association p
value for each CpG site. The sites with p < 0.05/nprobes
are included in the first component with the remainder
feeding into a second component. These components
are then fitted as random effects in the model to control
for confounding. However, convergence issues can occur
when a large number of CpGs are included in the first
component, as is the case with EWASs of age and sex.
To account for this, we implemented a stepwise
selection procedure to avoid saturation of the first com-
ponent (MOMENT2; http://cnsgenomics.com/software/
osca/#EWAS). In the age EWAS models, we pre-
adjusted the methylation data for sex and batch.
Additional adjustment for cell counts and smoking re-
sulted in genomic deflation due to collinearity between
these covariates and age. In the sex EWAS models, we
pre-adjusted the methylation data for age and batch. For
the age-by-sex interaction EWAS models, the methyla-
tion data were pre-adjusted for age, sex, smoking status,
smoking pack-year, cell types, and batch, and the age-
by-sex interaction outcome was adjusted for age and
sex. A default threshold (p < 0.05/nprobes) was used to
select probes for the first component, prior to the
stepwise analysis, for all models. The only exception
was the sex EWAS in the replication cohort where
this threshold was increased to p < 1 × 10−20 to enable
model convergence. Probes with a p value less than
3.6 × 10−8 [23] were considered epigenome-wide sig-
nificant associations.
Pathway analysis
Enrichment was assessed among the KEGG pathways
and Gene Ontology (GO) terms using the gometh()
function in the missMethyl package in R [24]. This func-
tion models the relationship between the number of
probes per gene and the probability of being selected,
accounting for the selection bias associated with probe-
dense genes.
Results
Sample demographics
The genetically unrelated subset of Generation Scotland
(discovery cohort) had a mean age of 50 years (SD =
12.5) and comprised 1587 females (61.4%) and 999 males
(38.6%). Males ranged in age from 18.1 to 85.7 years
(mean = 50.8 years, SD = 12.2) whereas females ranged
from 18.0 to 86.9 years (mean = 49.5 years, SD = 12.7).
The replication cohort had a mean age of 51.4 years
(SD = 13.2) and comprised 2506 females (56.3%) and
1944 males (43.7%). Males ranged in age from 18.1 to
86.5 years (mean = 52.0 years, SD = 13.3) whereas females
ranged from 18.1 years to 93.3 years (mean = 50.9 years,
SD = 13.1).
DNAm and chronological age
Using a linear regression (LR) model approach that did
not adjust for inter-probe correlations, there were 250,485
autosomal and 3096 X-linked CpGs associated with
chronological age at the epigenome-wide significant level
(p < 3.6 × 10−8) in the discovery cohort. 151,537 autosomal
and 1668 X-linked sites were epigenome-wide significant
with the effect sizes in the same direction in the replica-
tion cohort (Fig. 1; Additional file 1: Tables S1-S2); 68,038
of these CpGs showed increasing methylation with age.
High genomic inflation was observed with lambda values
ranging from 12.2 to 57.1 (Additional file 2: Figure. S1).
A mixed linear model (MLM) approach that adjusted
for inter-probe correlations and unmeasured con-
founders showed much better control of genomic
inflation (lambda values ranging from 0.96 to 1.03; Add-
itional file 2: Figure. S2). It identified 6 autosomal and 5
X-linked sites that were epigenome-wide significant with
the effect sizes in the same direction in both the discov-
ery and replication cohorts (Table 1). All of these sites
were included in the 153,205 sites reported in Fig. 1 and
Additional file 1: Tables S1-S2.
DNAm and sex differences on the autosomes
There were 134,649 autosomal CpGs associated with sex
at the epigenome-wide significant level (p < 3.6 × 10−8) in
the discovery cohort; 69,384 were epigenome-wide sig-
nificant with the effect sizes in the same direction in the
replication cohort (Fig. 1; Additional file 1: Table S3). As
with age, high genomic inflation was observed with
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lambda values ranging from 14.4 to 16.4 (Additional file 2:
Figure. S3). The MLM approach that adjusted for inter-
probe correlations and unmeasured confounders again
showed much better control of genomic inflation
(lambda values of 1.00 and 1.05; Additional file 2: Figure.
S4). It identified 4 autosomal sites that were epigenome-
wide significant with the effect sizes in the same direc-
tion in both the discovery and replication cohorts
(Table 1). All of these sites were included in the 69,384
sites reported in Fig. 1 and Additional file 1: Table S3.
DNAm and the interaction between chronological age
and sex
The LR model that did not adjust for inter-probe correla-
tions identified 85 autosomal and 635 X-linked CpGs that
showed different ageing trajectories by sex (Additional file 1:
Tables S4-S5; p < 3.6 × 10−8) in the discovery cohort. Fifty-
two autosomal and 597 X-linked sites replicated (same dir-
ection and p < 3.6 × 10−8) in the replication cohort (Fig. 1).
These mapped to 251 unique genes. Genomic inflation
ranged from lambdas of 1.11 and 6.29 (Additional file 2:
Figure. S5). A heterogeneity test between age EWAS out-
puts from sex-stratified models gave –log10 p values that
were highly correlated with the –log10 p values from the
interaction model (Additional file 2: Figure. S6).
The more conservative MLM approach (lambda range
0.94–1.00; Additional file 2: Figure. S7) identified four
autosomal and seven X-linked sites that were epigenome-
wide significant with the effect sizes in the same direction
in both the discovery and replication cohorts (Add-
itional file 1: Table S6). Nine of these sites were included
in the 649 sites reported in Fig. 1 and Tables S4-S5.
The probe with the greatest ageing-associated differ-
ence between males and females was cg15833111, map-
ping to GAGE10 on the X chromosome (Fig. 2;
interaction p < 1.41 × 10−23 in all LR and MLM models).
In the discovery cohort, hypomethylation of this probe
was observed with increasing age in females (r = − 0.61),
whereas methylation levels remained stable in males (r =
0.02). Four of the 9 CpG sites identified as significant in
Fig. 1 Age, sex, and age-by-sex effects in discovery and replication cohorts (linear regression method). Discovery cohort effect sizes (x-axis) are
plotted against replication cohort effect sizes (y-axis) for the epigenome-wide analysis of age, sex, and age-by-sex. Autosomal and X-chromosome
associations are presented separately
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both cohorts and by both modelling approaches exhibited
clear differences in mean DNAm levels between males
and females across an adult age range (cg00531806,
cg08814148, cg20202246, cg24541420). These differences
ranged from 0.14 to 0.21 on the beta value scale. There
were significant main effects for both age and sex for 239
of the 649 probes (13 autosomal and 226 X-linked).
To investigate whether X chromosome inactivation
(XCI) affected the 217 genes mapping to the 597 X-
linked CpGs identified in this analysis, the genes were
queried against a list of 114 XCI-escaping genes [25].
Thirty-two age-by-sex-associated genes were present in
the list of 114 XCI escapees. There was an enrichment
of XCI escapee genes in the list of age-by-sex-associated
genes (χ2 = 4.19; p = 0.04) with 14.7% of the 217 age-by-
sex associated genes being XCI escapees versus 9.6% in
the remaining 850 genes (based on the EPIC array anno-
tation) on the X chromosome.
Table 1 Age, sex, and age-by-sex associations common to discovery and replication cohorts using both linear regression and
MOMENT methods. The results shown correspond to the MOMENT output
Probe Chr BP Gene Orientation Discovery
b
Discovery
se
Discovery
p
Replication
b
Replication
se
Replication
p
Phenotype
cg08097417 7 130,419,
133
KLF14 – 4.26 0.40 5E−27 2.45 0.23 7E−27 Age
cg16867657 6 11,044,877 ELOVL2 + 5.05 0.40 4E−36 4.85 0.27 4E−71 Age
cg10501210 1 207,997,
020
NA + − 1.90 0.19 3E−23 − 1.20 0.12 4E−23 Age
cg07553761 3 160,167,
977
TRIM59 + 1.91 0.33 4E−09 1.25 0.20 1E−10 Age
cg23606718 2 131,513,
927
FAM123C + 2.45 0.32 1E−14 1.83 0.23 1E−15 Age
cg02872546 2 109,741,
578
NA – − 3.63 0.51 6E−13 − 1.94 0.33 2E−09 Age
cg20351734 X 73,571,783 NA – − 6.90 0.63 4E−28 − 5.81 0.44 4E−39 Age
cg15833111 X 49,166,019 GAGE10 + − 3.60 0.46 3E−15 − 2.41 0.26 3E−21 Age
cg25140188 X 31,087,348 NA + − 1.81 0.29 6E−10 − 1.49 0.21 9E−13 Age
cg13466600 X 77,587,444 NA + − 6.10 0.71 8E−18 − 3.63 0.46 5E−15 Age
cg05517106 X 135,286,
461
FHL1 + − 2.97 0.49 1E−09 − 2.43 0.36 2E−11 Age
cg11643285 3 16,411,667 RFTN1 + − 0.09 0.01 2E−19 − 0.16 0.01 5E−122 Sex
cg09516963 12 68,042,445 DYRK2 – − 0.06 0.01 8E−22 − 0.07 3.91E-3 2E−75 Sex
cg05100634 18 45,457,604 SMAD2 – − 0.06 0.01 2E−30 − 0.03 4.46E-3 2E−11 Sex
cg10334916 2 241,508,
098
RNPEPL1 + 0.03 0.01 2E−08 0.02 3.92E-3 2E−09 Sex
cg16532938 2 164,584,
635
FIGN – − 0.12 0.02 1E−09 − 0.15 0.01 3E−22 Age-by-
sex
cg06072257 1 11,434,636 NA + − 0.27 0.04 1E−11 − 0.33 0.04 3E−18 Age-by-
sex
cg00531806 4 190,938,
709
NA – − 0.12 0.02 4E−11 − 0.14 0.02 3E−16 Age-by-
sex
cg15833111 X 49,166,019 GAGE10 + 0.22 0.02 1E−23 0.14 0.01 6E−27 Age-by-
sex
cg05548968 X 30,928,416 NA – 0.14 0.02 4E−14 0.08 0.01 5E−09 Age-by-
sex
cg15475625 X 9,042,463 NA – 0.21 0.03 1E−12 0.18 0.02 3E−14 Age-by-
sex
cg20202246 X 118,407,
296
NA – 0.21 0.03 7E−13 0.23 0.03 1E−15 Age-by-
sex
cg08814148 X 118,407,
645
NA + 0.12 0.02 5E−10 0.13 0.01 8E−18 Age-by-
sex
cg24541420 X 135,691,
028
NA – − 0.16 0.02 1E−15 − 0.12 0.01 4E−16 Age-by-
sex
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Genes mapping to the 649 probes identified and repli-
cated in the LR analysis were queried against published
GWAS results (GWAS catalog[26]) to determine whether
there was an enrichment among specific traits. Consider-
ing SNPs located within 1Mb of a given age-by-sex-asso-
ciated CpG site yielded 98 genome-wide significant
associations (p < 5 × 10−8) comprising 73 SNPs (Add-
itional file 1: Table S7) [27]. Several associations were with
sexually dimorphic traits (e.g. prostate cancer, systemic
lupus erythematosus, male pattern baldness, body mass
index) [28–37]. All of the SNPs were located on the X
chromosome. Of the 649 probes significantly associated
with the age-sex interaction, 399 were also present on the
Illumina 450K array (all of which were X-linked). These
were queried against the ARIES methylation Quantitative
Trait Locus (mQTL) database (mQTLdb [38];). There
were 9664 CpG-SNP associations reported comprising
4582 unique SNPs and 279 unique CpGs (Additional file 1:
Fig. 2 Pseudo-trajectories of DNA methylation by sex for probes associated with the age-by-sex interaction term using linear regression and MOMENT
methods. DNA methylation beta values (y-axis) are plotted against chronological age (x-axis) separately for male samples (purple points) and female
samples (orange points). Red lines represent the regression slope for the univariate model DNAm~ age. Grey contour lines indicate data density
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Table S8). Two mQTL SNPs were present in the 73 SNPs
identified from the GWAS catalogue query. These were
associated with male pattern baldness and prostate cancer
[31, 36]. The prostate cancer-associated SNP (rs17321482)
is a QTL in an adolescent sample for the genome-wide
significant age-by-sex CpG (cg23722529), mapping to
ARHGAP6. Figure 3 shows a plot of methylation at
cg23722529 by age, stratified by sex and genotype for
rs17321482 in the discovery cohort. A simple linear regres-
sion model of CpG on the interaction between genotype
and age suggested no association between DNA methyla-
tion and age in either sex (male interaction Page_T = 0.40, fe-
male interaction Page_CT = 0.86, Page_TT = 0.82). Whereas
ascertainment bias (e.g. sampling healthier older males or
those that survive prostate cancer) may have been driving
the association between cg23722529 and age in men, there
was a minimal difference in the effect sizes in the whole
population versus those aged under 60 years (βall = −
0.0047, p = 1.2 × 10−4; β< 60 = − 0.0043, p = 5.5 × 10
−3). The
male pattern baldness SNP (rs79798752) maps to EDA2R,
within ~ 554 kb from the EWAS CpG (cg15343840—an
EPIC array-specific CpG) in the same gene. This SNP is a
QTL for a different probe (cg08021299), approximately
249 kb away and mapping to HEPH. The probe is also
among the 649 CpGs significantly associated with the age-
by-sex interaction.
Functional enrichment analysis
The 251 genes where differential methylation was associ-
ated with the age-by-sex interaction in the LR analysis
were assessed for enrichment in KEGG pathways, GO
terms, and tissue-specific expression in 30 general tis-
sues from GTEx v7 [24, 39].
There were no KEGG pathways or GO terms enriched
for the genes associated with the age-by-sex interaction
after correction for multiple testing (Bonferroni-adjusted
p < 0.05; Additional file 1: Tables S9-S10). The strongest
enrichment was observed among downregulated genes
in the testis and upregulated genes in the brain regions
including thy hypothalamus and hippocampus (Fig. 4).
Fig. 3 DNA methylation by genotype at the prostate cancer-associated variant rs17321482. DNA methylation beta values (y-axis) are plotted
against chronological age (x-axis) separately for male samples (purple points) and female samples (orange points), based on genotype at
rs17321482. Red lines represent the regression slope for the univariate model DNAm~ age. Black contour lines indicate data density
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Discussion
Using a combination of standard linear regression methods
and a more conservative mixed modelling method, we have
identified loci displaying sexually dimorphic ageing associa-
tions in DNAm across the adult age range. These associa-
tions were predominantly X-linked. Of the nine CpGs
identified by both methods, two mapped to genes (GAGE10
and FIGN).
The site with the greatest absolute age-DNAm correl-
ation difference between males and females mapped to
GAGE10, a member of the GAGE cancer/testis antigen
family [40]. Normal expression of GAGE proteins is lim-
ited to germ cells. However, GAGE transcripts have been
observed in multiple cancers including melanomas and
breast, lung, ovarian, and thyroid cancers [40–46].
The majority of age-by-sex-associated genes did not
return results when queried in the GWAS catalogue.
This is not surprising as the X chromosome is usually
omitted from association studies [47]. However, of the
associations identified, several pertained to sexually
Fig. 4 Enrichment of age-by-sex-associated genes among differentially expressed genes by tissue. The figure shows enrichment among
differentially expressed genes in a given tissue (x-axis) compared to all other tissue types. The enrichment –log10(p value) is shown on the y-axis.
Tissues with significant enrichment of genes are highlighted in red
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dimorphic traits. A variant in ARGHAP6, an age-by-sex-
associated gene from this study, has previously been
linked to prostate cancer [31]. However, there was no
effect of this genotype on the age-by-sex interaction.
Further examination of interactions between DNA
methylation and disease-related genetic risk factors in a
longitudinal context is warranted.
The mQTLdb resource is limited to probes present on
the Infinium Human Methylation 450K BeadChip—the
predecessor of the Infinium MethylationEPIC BeadChip
used in the current study [38]. Of the 649 sites queried
for mQTLs, 399 were present on both platforms. It is,
therefore, possible that additional, as-yet-unidentified
SNP associations are present among the remaining sites
specific to the Infinium MethylationEPIC BeadChip.
Analysis of tissue-specific expression patterns of the
genes displaying sexually dimorphic age-associated DNAm
trajectories revealed strong enrichment among differentially
expressed genes in the testis and brain regions, including
the hypothalamus. Enrichment among differentially
expressed genes in the testis may be indicative of a relation-
ship with endocrine function and sex-specific ageing. This
is consistent with the current hypotheses of endocrine dif-
ferences as a contributor to the disparity in the life expect-
ancy of males and females [48–50]. Additionally, the
hypothalamus displays anatomical, ontogenetic, and bio-
chemical differences between males and females [51]. The
present findings may further delineate the established con-
tribution of differential DNAm profiles to sex-specific dis-
parities in the brain structure and function [52, 53].
In addition to the age-by-sex interaction, we examined
the relationship between DNAm and both chronological
age and sex. We replicated previous findings, with the
strongest age-associated effects observed in KLF14,
ELOVL2, and FHL2 [14, 15] and sex-associated effects
observed in RFTN1 [54]. As replication was observed
using both the liberal LR method and the more conser-
vative MLM approach, these genes should be prioritised
for further functional investigation in studies of ageing
and sexually dimorphic traits.
The current study is strengthened by the use of large, un-
related discovery and replication cohorts with a broad age
range, which has permitted the development of pseudo-
longitudinal profiles of DNAm across the life course in
males and females. An additional strength is the use of two
modelling approaches. The more liberal linear regression
approach does not account for correlations which may be
present between probes and is prone to genomic inflation.
However, in the current study, we accompanied our ana-
lysis with a more conservative mixed linear modelling ap-
proach (called MOMENT), which accounts for the
relationship between a given probe and trait with distal
probes fitted in multiple random effect components [22].
This approach can account for unobserved confounders
and reduce inflation. However, this also poses a limitation
in that results based on this method may be overly conser-
vative. This is evidenced by the small number of age and
sex associations identified using MOMENT.
Conclusions
We identified 649 CpG sites displaying differences in age-
associated DNAm patterns between males and females.
The majority of these sites are located on the X chromo-
some, several of which are within genes associated with
sexually dimorphic traits by GWAS, including prostate
cancer and male pattern baldness. In order to identify the
mechanisms of sex-specific differences in biological age-
ing, further investigation of sexually dimorphic character-
istics of these processes over the life course is warranted.
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